(JNJ) |
| 0 (0%) 04-14 05:04 |
| Open: | |
| High: | |
| Low: | |
| Volume: | 0 |
| Market Cap: | 0(M) |
| PE Ratio: | 0 |
| Exchange: | |
| Industry: | |
| Sector: |
| Technical analysis | ||||
![]() |
||||
| sell | buy | |||
| Resistance 2: | 247.21 |
| Resistance 1: | 241.49 |
| Pivot price: | 240.19 |
| Support 1: | 232.24 |
| Support 2: | 193.22 |
| 52w High: | |
| 52w Low: |
| EPS | 11.040 |
| Book Value | 33.870 |
| PEG Ratio | 0.00 |
| Gross Profit | 26.610 |
| Profit Margin (%) | 28.46 |
| Operating Margin (%) | 23.97 |
| Return on Assets (ttm) | 8.7 |
| Return on Equity (ttm) | 35.0 |
Mon, 13 Apr 2026
Johnson & Johnson Earnings Are Tuesday. Oncology Is Powering Growth. - Barron's
Mon, 13 Apr 2026
Polymarket Odds: Will BLK, JPM, JNJ Beat Earnings Tomorrow? - TipRanks
Mon, 13 Apr 2026
Johnson & Johnson reports positive Varipulse results at EHRA 2026 - MassDevice
Mon, 13 Apr 2026
Johnson & Johnson Q1 preview: What to expect - Seeking Alpha
Mon, 13 Apr 2026
Ahead of Q1 Earnings, What Do Analysts Think About Johnson & Johnson Stock (JNJ)? - TipRanks
Mon, 13 Apr 2026
Johnson & Johnson (JNJ) is Gaining from Its Strong Innovative Medicine Growth - Yahoo Finance
|
StockChart iOS |
StoxlineLite iOS |
StoxlineLite iOS |
OptionCalc iOS |
|
StockChart Android |
StoxlineLite Android |
StoxlinePro Android |
OptionCalc Android |